Insomnia Therapy Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Insomnia Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insomnia Therapy Overall Market Size
2.1 Global Insomnia Therapy Market Size: 2021 VS 2027
2.2 Global Insomnia Therapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Therapy Players in Global Market
3.2 Top Global Insomnia Therapy Companies Ranked by Revenue
3.3 Global Insomnia Therapy Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Therapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Insomnia Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Therapy Players in Global Market
3.6.1 List of Global Tier 1 Insomnia Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Insomnia Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Insomnia Therapy Market Size Markets, 2021 & 2027
4.1.2 Non-pharmacological Therapy
4.1.3 Pharmacological Therapy
4.2 By Type - Global Insomnia Therapy Revenue & Forecasts
4.2.1 By Type - Global Insomnia Therapy Revenue, 2016-2021
4.2.2 By Type - Global Insomnia Therapy Revenue, 2022-2027
4.2.3 By Type - Global Insomnia Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insomnia Therapy Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Ambulatory Surgical Center
5.1.4 Home Care
5.2 By Application - Global Insomnia Therapy Revenue & Forecasts
5.2.1 By Application - Global Insomnia Therapy Revenue, 2016-2021
5.2.2 By Application - Global Insomnia Therapy Revenue, 2022-2027
5.2.3 By Application - Global Insomnia Therapy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Insomnia Therapy Market Size, 2021 & 2027
6.2 By Region - Global Insomnia Therapy Revenue & Forecasts
6.2.1 By Region - Global Insomnia Therapy Revenue, 2016-2021
6.2.2 By Region - Global Insomnia Therapy Revenue, 2022-2027
6.2.3 By Region - Global Insomnia Therapy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Insomnia Therapy Revenue, 2016-2027
6.3.2 US Insomnia Therapy Market Size, 2016-2027
6.3.3 Canada Insomnia Therapy Market Size, 2016-2027
6.3.4 Mexico Insomnia Therapy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Insomnia Therapy Revenue, 2016-2027
6.4.2 Germany Insomnia Therapy Market Size, 2016-2027
6.4.3 France Insomnia Therapy Market Size, 2016-2027
6.4.4 U.K. Insomnia Therapy Market Size, 2016-2027
6.4.5 Italy Insomnia Therapy Market Size, 2016-2027
6.4.6 Russia Insomnia Therapy Market Size, 2016-2027
6.4.7 Nordic Countries Insomnia Therapy Market Size, 2016-2027
6.4.8 Benelux Insomnia Therapy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Insomnia Therapy Revenue, 2016-2027
6.5.2 China Insomnia Therapy Market Size, 2016-2027
6.5.3 Japan Insomnia Therapy Market Size, 2016-2027
6.5.4 South Korea Insomnia Therapy Market Size, 2016-2027
6.5.5 Southeast Asia Insomnia Therapy Market Size, 2016-2027
6.5.6 India Insomnia Therapy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Insomnia Therapy Revenue, 2016-2027
6.6.2 Brazil Insomnia Therapy Market Size, 2016-2027
6.6.3 Argentina Insomnia Therapy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Insomnia Therapy Revenue, 2016-2027
6.7.2 Turkey Insomnia Therapy Market Size, 2016-2027
6.7.3 Israel Insomnia Therapy Market Size, 2016-2027
6.7.4 Saudi Arabia Insomnia Therapy Market Size, 2016-2027
6.7.5 UAE Insomnia Therapy Market Size, 2016-2027
7 Players Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Corporate Summary
7.1.2 Merck & Co. Business Overview
7.1.3 Merck & Co. Insomnia Therapy Major Product Offerings
7.1.4 Merck & Co. Insomnia Therapy Revenue in Global (2016-2021)
7.1.5 Merck & Co. Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Insomnia Therapy Major Product Offerings
7.2.4 Sanofi Insomnia Therapy Revenue in Global (2016-2021)
7.2.5 Sanofi Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Insomnia Therapy Major Product Offerings
7.3.4 Pfizer Insomnia Therapy Revenue in Global (2016-2021)
7.3.5 Pfizer Key News
7.4 Takeda Pharmaceutical Company Ltd.
7.4.1 Takeda Pharmaceutical Company Ltd. Corporate Summary
7.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
7.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Major Product Offerings
7.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue in Global (2016-2021)
7.4.5 Takeda Pharmaceutical Company Ltd. Key News
7.5 Purdue Pharmaceuticals L.P.
7.5.1 Purdue Pharmaceuticals L.P. Corporate Summary
7.5.2 Purdue Pharmaceuticals L.P. Business Overview
7.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Major Product Offerings
7.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue in Global (2016-2021)
7.5.5 Purdue Pharmaceuticals L.P. Key News
7.6 Eisai, Co. Ltd.
7.6.1 Eisai, Co. Ltd. Corporate Summary
7.6.2 Eisai, Co. Ltd. Business Overview
7.6.3 Eisai, Co. Ltd. Insomnia Therapy Major Product Offerings
7.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue in Global (2016-2021)
7.6.5 Eisai, Co. Ltd. Key News
7.7 Meda Consumer Healthcare
7.7.1 Meda Consumer Healthcare Corporate Summary
7.7.2 Meda Consumer Healthcare Business Overview
7.7.3 Meda Consumer Healthcare Insomnia Therapy Major Product Offerings
7.4.4 Meda Consumer Healthcare Insomnia Therapy Revenue in Global (2016-2021)
7.7.5 Meda Consumer Healthcare Key News
7.8 Pernix Therapeutics
7.8.1 Pernix Therapeutics Corporate Summary
7.8.2 Pernix Therapeutics Business Overview
7.8.3 Pernix Therapeutics Insomnia Therapy Major Product Offerings
7.8.4 Pernix Therapeutics Insomnia Therapy Revenue in Global (2016-2021)
7.8.5 Pernix Therapeutics Key News
7.9 Vanda Pharmaceuticals
7.9.1 Vanda Pharmaceuticals Corporate Summary
7.9.2 Vanda Pharmaceuticals Business Overview
7.9.3 Vanda Pharmaceuticals Insomnia Therapy Major Product Offerings
7.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue in Global (2016-2021)
7.9.5 Vanda Pharmaceuticals Key News
7.10 ECR Pharmaceuticals
7.10.1 ECR Pharmaceuticals Corporate Summary
7.10.2 ECR Pharmaceuticals Business Overview
7.10.3 ECR Pharmaceuticals Insomnia Therapy Major Product Offerings
7.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue in Global (2016-2021)
7.10.5 ECR Pharmaceuticals Key News
7.11 Fidia Farmaceutici
7.11.1 Fidia Farmaceutici Corporate Summary
7.11.2 Fidia Farmaceutici Business Overview
7.11.3 Fidia Farmaceutici Insomnia Therapy Major Product Offerings
7.11.4 Fidia Farmaceutici Insomnia Therapy Revenue in Global (2016-2021)
7.11.5 Fidia Farmaceutici Key News
7.12 Dainippon Sumitomo
7.12.1 Dainippon Sumitomo Corporate Summary
7.12.2 Dainippon Sumitomo Business Overview
7.12.3 Dainippon Sumitomo Insomnia Therapy Major Product Offerings
7.12.4 Dainippon Sumitomo Insomnia Therapy Revenue in Global (2016-2021)
7.12.5 Dainippon Sumitomo Key News
7.13 Biocodex
7.13.1 Biocodex Corporate Summary
7.13.2 Biocodex Business Overview
7.13.3 Biocodex Insomnia Therapy Major Product Offerings
7.13.4 Biocodex Insomnia Therapy Revenue in Global (2016-2021)
7.13.5 Biocodex Key News
7.14 Eli Lilly and Company
7.14.1 Eli Lilly and Company Corporate Summary
7.14.2 Eli Lilly and Company Business Overview
7.14.3 Eli Lilly and Company Insomnia Therapy Major Product Offerings
7.14.4 Eli Lilly and Company Insomnia Therapy Revenue in Global (2016-2021)
7.14.5 Eli Lilly and Company Key News
7.15 Ebb Therapeutics
7.15.1 Ebb Therapeutics Corporate Summary
7.15.2 Ebb Therapeutics Business Overview
7.15.3 Ebb Therapeutics Insomnia Therapy Major Product Offerings
7.15.4 Ebb Therapeutics Insomnia Therapy Revenue in Global (2016-2021)
7.15.5 Ebb Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Insomnia Therapy Market Opportunities & Trends in Global Market
Table 2. Insomnia Therapy Market Drivers in Global Market
Table 3. Insomnia Therapy Market Restraints in Global Market
Table 4. Key Players of Insomnia Therapy in Global Market
Table 5. Top Insomnia Therapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Insomnia Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Insomnia Therapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Insomnia Therapy Product Type
Table 9. List of Global Tier 1 Insomnia Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insomnia Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics